Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
Summary:
Open House Discount Agreements 2024-14 Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Jan 2027 Posting Date:
16 Dec 2024 |
Summary:
Open Framework Agreement On Drug Discounts Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) With The Option To Join At Any Time, So-Called Approval Model 2025-02" Of The German Pension Insurance Knappschaft-Bahn-See Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Dec 2026 Posting Date:
13 Dec 2024 |
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Minoxidil (C02Dc01) Within The Framework Of A So-Called Open-House Model. Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
12 Dec 2024 |
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (L03Aa13) Within The Framework Of A So-Called Open-House Model. Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
12 Dec 2024 |
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Acetylsalicylic Acid (B01Ac06) Within The Framework Of A So-Called Open-House Model. Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
12 Dec 2024 |
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dornase Alfa (R05Cb13) Within The Framework Of A So-Called Open-House Model. Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
12 Dec 2024 |
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Peginterferon Beta-1A (L03Ab13) Within The Framework Of A So-Called Open-House Model. Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
12 Dec 2024 |
Summary:
Medicines Containing The Active Ingredient Budesonide (Atc: A07Ea06) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Nov 2026 Posting Date:
09 Dec 2024 |
Germany human medicine Tenders Contracts and Bids
Find Germany human medicine tenders and government contracts. Search business opportunities for Germany human medicine tenders, Germany generic medicine tenders, Germany antibiotics medicine tenders, Germany homeopathy medicine tenders..